| 영문 | Dilatation and Curettage(D & C) | 한글 | 자궁긁어냄술, 자궁목확장 |
|---|---|---|---|
| 설명 | 자궁이란 태아가 수태되어서 분만전까지 발육하고 성장하는 공간이다. 자궁속에 병변이 있어 임신이 계속될 수 없거나 아니면 다른 이유로 임신되어 있는 태아를 제거하고자 할 경우에 사용되는 방법이다. 여기서 긁어내기 위하여는 우선 자궁의 입구에 해당하는 자궁목을 확장시켜야 한다. 여기에는 급속히 확장을 시도하는 법과 서서히 확장을 시도하는 2가지 방법이 있다. 자궁목을 급속히 확장할 때는 헤가르 목관확장기(Hegar's dilatator)를 사용한다. 이것은 작은 금속막대로 작은 크기부터 큰 크기까지 다양한 크기가 있어서 우선 작은 막대로 시작하여 점점 큰 크기의 막대를 자궁목에 넣어서 자궁목을 확장시킨다. 서서히 확장시킬 때는 Laminaria tent를 목관에 삽입하는 방법을 사용한다. Laminaria tent란 해초로 만든 작은 막대로 수분을 흡수하면 점점 늘어나는 성질이 있다. 이것을 자궁의 목에 넣으면 이것이 수분을 흡수하여 늘어나므로 천천히 자궁의 목이 늘어난다. 자궁목이 충분히 늘어나면 그 속으로 끝이 숟가락처럼 생긴 기구를 넣어서 자궁속의 병변이나 임신된 태아를 긁어내는데 여기에 사용되는 숟가락처럼 생긴 기구를 큐렛이라고 한다. 초기 임신중절 즉 유산과 같은 임신과 관련된 경우뿐만 아니라, 비임신 자궁의 자궁내막조직의 채취 및 제거를 위해서도 행해지는 수기이다. 이는 원칙적으로 마취하에 실시되는 것으로 자궁목관을 확장하고 기구로 자궁 내용물을 제거하고 큐렛으로 자궁내벽을 깨끗이 한다. 자궁천공이나 자궁목의 파열 등의 위험이 따르며, 수술후 감염 또는 출혈 등에 대한 주의가 필요하다. |
||
| DME | degenerative myoclonus epilepsy; dimethyl diester; dimethyl ether; diphasic meningoencephalitis; dir... |
|---|---|
| AGBAD | Alexander Graham Bell Association for the Deaf |
| RNID | Royal National Institute for the Deaf |
| TDD | telecommunication device for the deaf; tetradecadiene; thoracic duct drainage; total digitalizing do... |
| AJKD | American Journal of Kidney Diseases |
| JAMA | Journal of the American Medical Association |
|---|---|
| NEJM | New England Journal of Medicine |
| IEC | Information, Education and Communication |
| NAEPP | National Asthma Education and Prevention Program |
| ACGME | Accreditation Council for Graduate Medical Education |
acute angle
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
|---|---|
| time and motion studies | The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task. (12 Dec 1998) |
| deaf | 1. Wanting the sense of hearing, either wholly or in part; unable to perceive sounds; hard of hearing; as, a deaf man. "Come on my right hand, for this ear is deaf." (Shak) 2. Unwilling to hear or listen; determinedly inattentive; regardless; not to be persuaded as to facts, argument, or exhortation; with to; as, deaf to reason. "O, that men's ears should be To counsel deaf, but not to flattery!" (Shak) 3. Deprived of the power of hearing; deafened. "Deaf with the noise, I took my hasty flight." (Dryden) 4. Obscurely heard; stifled; deadened. "A deaf murmur through the squadron went." (Dryden) 5. Decayed; tasteless; dead; as, a deaf nut; deaf corn. "If the season be unkindly and intemperate, they [peppers] will catch a blast; and then the seeds will be deaf, void, light, and naught." (Holland) Deaf and dumb, without the sense of hearing or the faculty of speech. See Deaf-mute. Origin: OE. Def, deaf, deef, AS. Deaf; akin to D. Doof, G. Taub, Icel. Daufr, Dan. Dov, Sw. Dof, Goth. Daubs, and prob. To E. Dumb (the original sense being, dull as applied to one of the senses), and perh. To Gr. (for) blind, smoke, vapor, folly, and to G. Toben to rage. Cf. Dumb. Source: Websters Dictionary (01 Mar 1998) |
| deaf-mute | An individual with deafmutism. (05 Mar 2000) |
| physical education and training | Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is exercise therapy. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|